Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the ...

Q3 2025 Management View John Sheridan, President and CEO, highlighted "significant strategic milestones and delivered record ...

In November 2025, Tandem Diabetes Care announced FDA clearance for the Android version of its Tandem Mobi mobile app, enabling broader access to its automated insulin delivery system for Android ...

Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after hours today on third-quarter results that came in ahead of the ...

Fintel reports that on November 10, 2025, Barclays maintained coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a ...

As of Friday, November 07, Tandem Diabetes Care, Inc.’s TNDM share price has surged by 23.56%, which has investors questioning if this is right time to sell.

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full ...

Tandem Diabetes Care achieves ISO/IEC 27001:2022 Certification, reinforcing commitment to global data security standards.

The FDA has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi mobile application.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2024 results after the financial markets ...

15 analysts have shared their evaluations of Tandem Diabetes Care (NASDAQ:TNDM) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collaboration agreement ...